Site icon UK Immigration Justice Watch Blog

Paposhvili and HIV/AIDS: First Tier Tribunal Judge allows Article 3 medical condition appeal by a Malawian claimant

In PAPOSHVILI v. BELGIUM – 41738/10 (Judgment (Merits and Just Satisfaction) : Court (Grand Chamber)) [2016] ECHR 1113, the ECHR stated,  “The Court concludes from this recapitulation of the case-law that the application of Article 3 of the Convention only in cases where the person facing expulsion is close to death, which has been its practice since the judgment in N. v. the United Kingdom, has deprived aliens who are seriously ill, but whose condition is less critical, of the benefit of that provision. As a corollary to this, the case-law subsequent to N. v. the United Kingdom has not provided more detailed guidance regarding the “very exceptional cases” referred to in N. v. the United Kingdom, other than the case contemplated in D. v. the United Kingdom”.

Following the decision in Paposhvili, a recent blog article enquired  as follows: Paposhvili ECHR: An Easing of The UK Courts Restrictive Approach To Article 3 Medical Condition Cases?  Over a  decade  has passed with Immigration Tribunal Judges  being  required to in effect almost  routinely  dismiss Article 3 medical condition appeals  originating  from claimants  living with HIV.   After Paposhvili however,   it appears that some Judges of the  First Tier Tribunal are  now daring to take the bull by horns and allow  medical condition human rights based appeals without the shadow  of  the case of “N”  constantly over their shoulders.

Has the Secretary of State amended  her policy guidance following Paposhvili?  No.  The current Policy Guidance,  Human Rights Claims On Medical Grounds, valid from 20 May 2014  still states:

“Considering article 3 medical claims

 

“Article 3 case law

 

Home Office policy for these applications is based on case law. For example, a key case, known as the case of ‘N’, was considered by the House of Lords and the European Court of Human Rights (ECtHR). The ECtHR judgment:

 

 

Following this case, Home Office policy is to accept that an applicant’s article 3 (medical) rights would be breached by removal to their country of origin only if:

 

………..

Referring the case before granting

 

As the tests for granting discretionary or indefinite leave under human rights (medical) grounds are very high, granting under this policy is rare. If you decide to grant such a case, you must refer the case to a senior caseworker before you do so”.

 

Published instructions to Home Office caseworkers are therefore that all Article 3 medical cases  have to meet the ‘N’ threshold.

 

Malawi: A recent example

 

For Malawi, currently,  the only published Country Policy and Information Notes on the Home Office website  relate to claims focused on  sexual orientation and gender identity.  The last  Home  Office Report in relation to Malawi  to  cater for  availability  and accessibility   of medical treatment for certain medical conditions  was the Malawi Country of Origin Information Report of October 2012.

 

A Malawian claimant had her  asylum claim( fear of subjection  to FGM for her young  daughter) and Article 3 claim refused by the Home Office  in April 2017.  She had advanced her claim without  the  benefit of legal representation.  No  reference was made to the  case of Paposhvili within the  refusal decision yet  considerable reliance was placed upon the case of N v SSHD (2005) UKHL 31( Paposhvili was published in December 2016).  Reference was also made  in the refusal decision to the above set out Policy guidance of 2014  in relation to medical condition cases.

 

The refusal decision also specifically  referred to a Home Office Country of origin Response dated 05/02/2016 Malawi- Medical Issues: Treatment for HIV. AIDS ref 11/15/-044. This response was  stated to   have been  compiled  and researched by the Country Policy  and Information Team(CPIT) after researching  publicly accessible information and/or obtaining  information that can be made publicly available within time constraints.   In order to obtain the Response the  facts that had been put forward  were  as  follows:

 

The applicant is suffering from HIV since 2009, states his CD4 count is currently   undetectable. Applicant also states he suffers from depression, castleman  disease and Nodal Kaposi Sarcoma. Applicant  claims his Castleman  and Sarcoma diseases  will return if he fails to receive  HIV medication. Applicant claims  his doctors have  predicted  that the risk of Castleman or Sarcoma  returning is between 9 and 20%. Applicant is treating  his HIV with  Truvada and Intelence. He is  currently  taking Mirtazapine  and Venlafaxine  for depression. Applicant is not taking medication  for Castleman  or Sarcoma  diseases  at the moment.

Information requested:

The applicant is a Malawian male who suffers   from HIV, Castleman disease, sarcoma and depression. Please confirm availability  and accessibility of the medication  he is currently  taking( listed above) and please list any other  medications/treatments available  to him in Malawi. Please confirm  if this medication is provided free of charge, or if it costs money. Please also confirm  how widespread the availability  of the medication is.  Please also confirm the availability  of mental health support in Malawi  as the applicant claims to have experienced  suicidal thoughts. The applicant also claims  he has had two twin  children in the UK. They were born premature and are receiving  treatment, however  specific  information on the nature  of this treatment  has not been  provided. Is specialist  care for premature  babies available in Malawi?

 

The Response of 5 February  2016 stated:

 

“A medCOI response dated 1 February 2016 stated that there are specialists in Malawi who can treat people with HIV/AIDS. CD4 counts, viral loads and blood counts can be carried out in Malawi. Immunologists are not available in Malawi. Radiation therapy for the treatment  of  Kaposi sarcoma, ongoing  outpatient treatment  by a radiologist and treatment by  dermatologists are not available in Malawi.

 

Etravirine( HIV/AIDS), agomelatine ( anti- depressant), buproprion( anti-depressant) , mainserin( anti depressant), and moclobemide (anti-depressant) are not available.  Truvuda ( HIV/AIDS Mirtazapine( anti- depressant) , venlafaxine hydrochloride ( anti- depressant), setraline ( anti- depressant), duloxetine (anti- depressant), paroxetine (anti-  depressant) are all available. There are psychologists available in Malawi who can treat people  with mental  illness.

 

The cost, accessibility and how widespread the availability of a particular  type of medical care is  in a particular  country is outside  the remit  of MedCOI.

 

CPIT could not find information about specialist medical  care for babies who are born premature in Malawi”.

 

Relevant paragraphs of Paposhvili  relied upon in relation to the  appeal were as follows:

 

 

How the Immigration Judge approached the appeal

 

Although the asylum appeal was also allowed, the Immigration Judge relevantly had regard to the following, in summary,  by way of consideration and conclusion:

 

 

Conclusion

 

From the above, it is  therefore possible  for an Appellant to advance an Article 3  medical condition appeal  placing reliance upon Paposhvili and succeed.

 

Whilst the First Tier Tribunal  considers  matters  on the same ground( medical conditions cases)  applying the Paposhvili approach,  surely  the Home Office  cannot continue much longer  doing so from another angle ie the “N” approach.  The current Home Office policy guidance on medical  condition  cases   urgently  needs to be amended/updated so that  Home Office caseworkers  can attempt to  reach proper and  effective decisions that cater  for changes in caselaw.

 

As per  the contents of  the old style  CIPU or COI  reports which have now been abandoned, it is clear that the Home Office will now need to  formulate  specific Country policy and Information Notes  focused on  accessibility  and availability of  various forms of  medical conditions and  their  treatment in relation to several countries, so as  to cater for the  resurrection and wave of medical condition claims  that are  surely forthcoming.

 

Exit mobile version